---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-036130"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T01:19:08.840739+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# LifeMD appoints Kathleen E. Walsh to Board; grants 75,000 restricted shares and 37,500 stock options

## Summary
- Kathleen E. Walsh appointed to Board on Dec 15, 2022; she is President & CEO of Boston Medical Center.
- Received 75,000 restricted shares (37,500 vest immediately, 37,500 vest in 2 years).
- Also received option to purchase 37,500 shares, vesting in 2 years.
- Will receive $6,000 per quarter as Board compensation.

## SEC filing metadata
- accession: 0001493152-22-036130
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315222036130/0001493152-22-036130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315222036130/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-036130
- JSON: https://secwatch.observer/filing/0001493152-22-036130.json
- Plain text: https://secwatch.observer/filing/0001493152-22-036130.txt

## Key facts
- Executive change
  Kathleen E. Walsh was appointed as director at LifeMD, Inc..
  - Action: appointed
  - Role: director
  source text: On December 15, 2022, LifeMD, Inc. (the “Company”) appointed Kathleen E. Walsh to the board of directors (the “Board”) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/948320/000149315222036130/0001493152-22-036130-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.